The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Impact of COVID-19 on the regulatory approval process

Name: Impact of COVID-19 on the regulatory approval process
Uploaded: 2021-01-15T00:00:00Z
Duration: 2 min 9 s
Description: Lola A. Fashoyin-Aje, MD, MPH, U.S. Food and Drug Administration, outlines how the COVID-19 pandemic has impacted the trials and approvals process and what adaptations have been implemented by the FDA, with the importance of preserving the safety of patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Lola A. Fashoyin-Aje • 15 Jan 2021

ASCO GI 2021

Gastrointestinal Cancer

Lola A. Fashoyin-Aje, MD, MPH, U.S. Food and Drug Administration, outlines how the COVID-19 pandemic has impacted the trials and approvals process and what adaptations have been implemented by the FDA, with the importance of preserving the safety of patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).